As a major player in the biopharmaceutical industry, AbbVie's insider trading activity is primarily characterized by stock sales from its key executives and directors. Monitoring the trading patterns of influential leaders, including the Chairman and Chief Executive Officer, can offer valuable insights. The company's board of directors and top executives are frequently involved in these transactions.
Join Stockcircle to see more insider trades and be the first to know about new executive transactions.
Sign Up
Gilead's once-daily pill emvistegrast helped 31% of patients reach clinical remission in a mid-stage trial for ulcerative colitis, beating placebo and opening a path to challeng...
StockCircle, about 1 month ago
AI
AI Generated
Treasuries now offer a yield that dividend investors once bragged about, which raises a question most retirees avoid asking: does an equity income portfolio actually come out ah...
247wallst.com, about 2 months ago
One analyst sees expanded uses for Rinvoq and Skyrizi propelling AbbVie stock to as much as $315 per share. This bull case makes sense and could be bolstered by AbbVie's further...
fool.com, about 2 months ago
ABBV's epcoritamab plus R-CHOP cut progression or death risk by 51% in frontline DLBCL, meeting the phase III study's PFS goal.
zacks.com, about 2 months ago
To improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.